Coverage
-
May 26, 2015
A Massachusetts federal judge Tuesday stayed Zogenix Inc.'s suit against the state over its regulatory restrictions on the company's controversial pure-hydrocodone drug Zohydro, awaiting the U.S. Food and Drug Administration's final action on the drug's labeling expected later this year.
4 other articles on this case.
View all »